Mental Health Clinics in Huntington, IN Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Pathfinder Services Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1152 E State St, Huntington, IN 46750 Phone: 260-356-0500 Fax: 260-356-3141 |
Lifespring Counseling Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 2303 College Ave, Huntington, IN 46750 Phone: 260-359-4002 |
New Hope Christian Counseling Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1740 E 675 N, Huntington, IN 46750 Phone: 219-386-3600 Fax: 219-386-3660 |
Allied Physicians Inc., D/b/a Fort Wayne Neurology Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 2001 Stults Rd, Suite 200, Huntington, IN 46750 Phone: 260-355-3150 |
Child's Play Behavior Analysis Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 2855 Northpark Ave, Huntington, IN 46750 Phone: 260-356-2222 |
News Archive
States to curb retiree benefits in search of savings
States are seeking savings in public employee retiree benefits to close sprawling budget gaps, Bloomberg Businessweek reports. "New Jersey and 20 other states are urging early retirements, cutting benefits and demanding employees contribute more in the face of what the Pew Center on the States says is a $1 trillion gap between available assets and what's owed workers."
Advocates push for integration of HIV/TB funding, programming in Kenya
This post in the Center for Global Health Policy's "Science Speaks" blog reports on a presentation at the Union World Conference on Lung Health in France on Saturday by Evelyne Kibuchi, a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), writing, "HIV stakeholders have been slow to embrace and adopt TB interventions, Kibuchi said, and resources for co-infection activities are modest.
Miserable mumps makes a comeback
There is concern in the UK at the growing number of outbreaks of mumps among children and young people.
Kenta Biotech presents positive Phase IIa results of panobacumab
Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.
New cardiac resynchronization therapy data in atrial fibrillation presented at Heart Rhythm 2011
Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions, shows the clinical benefit of cardiac resynchronization therapy versus conventional right-ventricle pacing in improving heart failure in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation.
› Verified 2 days ago